Dr Squatch price tag rumoured at $1.5bn in Unilever takeover.


The sale price of Unilever's takeover of men's grooming brand Dr Squatch is reported to have been $1.5bn, according to reports on Friday.

  • Unilever
  • 27 June 2025 08:12:09
Unilever

Source: Sharecast

The acquisition, from growth equity firm Summit Partners, was formally announced by all three companies on Monday, but press releases did not disclose any financial details.

While Unilever has said it will not reveal the terms of the deal, the Financial Times cited "several people familiar with the details" as saying the British consumer goods giant agreed to pay $1.5bn.

Dr Squatch, known for its natural soaps, body washes and deodorants with unique scents like wood barrel bourbon, and viral marketing campaigns with influencers and celebrities, "has grown to become a highly engaging men's personal care brand", Unilever said.

The brand's "culturally-relevant collaborations with limited-edition packs have helped to drive sales and grow a loyal consumer following on social media platforms and beyond".

Dr Squatch, which is primarily distributed in North America and Europe through digital commerce, retail and D2C channels, will be scaled internationally, according to Unilever.


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: 63.31 ( 0.72 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.